NeoPharm CO., LTD. (KOSDAQ:092730)
13,460
+340 (2.59%)
Apr 1, 2025, 3:30 PM KST
NeoPharm CO., LTD. Revenue
In the year 2024, NeoPharm CO., LTD. had annual revenue of 119.01B KRW with 22.56% growth. NeoPharm CO., LTD. had revenue of 34.03B in the quarter ending December 31, 2024, with 25.04% growth.
Revenue
119.01B
Revenue Growth
+22.56%
P/S Ratio
1.77
Revenue / Employee
672.39M
Employees
177
Market Cap
210.53B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 119.01B | 21.91B | 22.56% |
Dec 31, 2023 | 97.10B | 12.07B | 14.20% |
Dec 31, 2022 | 85.03B | -2.90B | -3.30% |
Dec 31, 2021 | 87.93B | 6.31B | 7.72% |
Dec 31, 2020 | 81.63B | -1.61B | -1.94% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
KT&G Corporation | 5,908.79B |
Amorepacific | 3,885.11B |
Samyang Foods | 1,728.02B |
LG H&H | 6,811.92B |
ORION | 3,104.34B |
CJ Cheiljedang | 29.36T |
Dong Suh Companies | 488.86B |
APR Co., Ltd. | 722.75B |